Talon Biomarkers

What Talon Biomarkers does

Talon Biomarkers is a founder-led, private biomarker discovery and immune monitoring services company headquartered in Whippany, New Jersey. The company was founded by Dr. Pratip Chattopadhyay, a recognized figure in cytometry whose prior work includes pioneering CD154-based identification of antigen-specific CD4+ T-cells and the first 18-color flow cytometry experiments. Talon targets pharmaceutical and biotechnology firms conducting translational research, immune monitoring, and clinical trial support, with a secondary segment of contract research organizations seeking specialized immune profiling capabilities.

The company's core platform integrates four laboratory and analytical capabilities: high-parameter flow cytometry and cell sorting, spatial and imaging cytometry, single-cell multi-omic profiling, and computational/dynamic analytics layered on time-resolved cytometry. A proprietary search tool called Flight Path Navigator, launched in early 2026, provides structured access to genetic, plasma/serum, cell type, and tissue biomarkers for study design. The stated differentiator versus traditional CROs is continuity of engagement from study design through data interpretation and long-term discovery planning, rather than sample delivery only. The revenue model is professional services, quote-based and tailored to project requirements, with no publicly disclosed pricing. The go-to-market is consultation-led, targeting enterprise pharma/biotech research and translational teams through direct engagement, supplemented by content marketing, LinkedIn presence, video content, and webinar participation. Capitalization to date consists of a single $75,000 grant from the New Jersey Commission on Science, Innovation and Technology, with no institutional investor backing evident in the available data.

Name

Talon Biomarkers

Legal name

Talon Biomarkers

Website

https://talonbiomarkers.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Talon Biomarkers is a private, founder-led biomarker discovery and immune monitoring services firm serving pharmaceutical and biotechnology clients with integrated multiomic profiling, high-dimensional cytometry, spatial analysis, and AI-driven interpretation.

Ownership category

akta.pro rank

Product category

Biomarker Discovery Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)

akta.pro secondary industries

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Biomarker Discovery & Validation (omics, assay feasibility, clinical validation) (HLAAAMAA), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF), Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Translational Medicine & Biomarkers (HLAIALAF)

Keywords

• Biomarker discovery services
• Immune monitoring solutions
• Multiomic profiling services
• Flow cytometry analysis
• Spatial imaging cytometry

Headquarters

HQ city

Whippany

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Biomarker Discovery Services: CRO-style biomarker discovery and immune monitoring services supporting analysis of cells, plasma, and tissues across research studies and clinical trials. Services include study design, execution, and data interpretation.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Talon Biomarkers operates as a scientific partner and contract research organization providing integrated biomarker discovery and immune monitoring services for pharmaceutical and biotech research teams. The company designs and executes immune analyses on cells, plasma, and tissues across research studies and clinical trials, delivering decision-ready insights that span study design through execution and data interpretation. Core capabilities include flow cytometry and cell sorting, spatial and imaging cytometry, single-cell multi-omic profiling, and computational and dynamic analytics, all unified within a coherent multiomic profiling framework.

Product overview

Talon Biomarkers offers a biomarker discovery platform with integrated immune monitoring services. The company provides a proprietary Flight Path Navigator tool for biomarker exploration, combined with core laboratory services including Flow Cytometry & Cell Sorting, Spatial & Imaging Cytometry, Single-Cell Multi-Omic Profiling, and Computational & Dynamic Analytics. These services support analysis of cells, plasma, and tissues across research studies and clinical trials, delivering decision-ready insights aligned to biological questions.

Differentiator

Problem solved

Functional benefit

Brands

• Flight Path Navigator: A proprietary search tool that helps researchers uncover research-backed biomarkers for their disease of interest, serving as a starting point for exploration and study design.

Products and services

• Flight Path Navigator Proprietary search tool that helps researchers uncover research-backed biomarkers for diseases of interest. Provides a structured view of the biomarker landscape including genetic, plasma/serum, cell type, and tissue biomarkers for exploration and study design.
• Flow Cytometry & Cell Sorting High parameter single cell profiling that resolves complex phenotypes and rare subsets, paired with precise sorting for downstream workflows. Targeted at pharma and biotech research teams running translational and clinical trial immune monitoring studies.
• Spatial & Imaging Cytometry Single cell spatial profiling that maps tissue architecture, microenvironments, and biomarker expression with high resolution. Serves translational researchers and clinical trial teams needing tissue-level immune analysis.
• Single-Cell Multi-Omic Profiling Molecular and transcriptomic analysis to define gene expression programs, pathway states, and clonal diversity across individual cells. Designed for immunotherapy development and translational medicine programs.
• Computational & Dynamic Analytics Computational modeling integrated with time-resolved cytometry to quantify kinetic behaviors, state transitions, and longitudinal immune dynamics. Supports drug development decision-making and immune monitoring across studies.
• Biomarker Discovery & Immune Monitoring Services End-to-end CRO-style biomarker discovery and immune monitoring service covering study design, execution, and data interpretation for pharmaceutical and biotechnology research programs. Supports analysis of cells, plasma, and tissues across research studies and clinical trials.
• Consultation and Scientific Partnership Scientific partnership and consultation service covering biomarker study design, experimental framework development, and data interpretation support for pharma and biotech clients. Positioned as ongoing collaborative engagement rather than transactional sample delivery.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

One partnership is on record.

• Technology PartnerscoreTechnology or Integration · 9 February 2024Talon has established technology partnerships to enhance their biomarker discovery and immune monitoring capabilities. These partnerships support the development of new experimental frameworks and analytical systems that expand what's possible in immune profiling, helping turn pioneering concepts from prototype to practice.

Recent moves6 records

Expansion highlights4 records

Direct peers

• CellCarta (formerly Caprion HistoGeneX): CellCarta is a specialty biomarker CRO offering flow cytometry, multiplexed immunoassays, and immune monitoring services to pharma/biotech sponsors. It is the closest direct peer to Talon — both position as scientific partners for translational immune profiling rather than commodity labs.
• FlowMetric: FlowMetric is a contract flow cytometry services provider focused on immune monitoring, cell sorting, and high-parameter panels for clinical and translational research. It competes directly with Talon's core flow cytometry & cell sorting offering for pharma/biotech sponsors.
• NeoGenomics Laboratories: NeoGenomics operates a specialty oncology and immune-profiling laboratory serving pharma clinical trials with flow cytometry, IHC, spatial, and NGS assays. It is a direct, but much larger, peer competing for the same translational biomarker programs.

Broad incumbents

• Charles River Laboratories: Charles River is a global CRO with established flow cytometry, biomarkers, and discovery services. It competes with Talon for translational pharma programs but as part of a much broader safety assessment and manufacturing portfolio.
• IQVIA: IQVIA is the largest global CRO with integrated lab, biomarker, and translational services. Its central labs and bioanalytical capability overlap with Talon's clinical-trial immune monitoring focus, with the scale and sponsor relationships that early-stage biomarker CROs must compete against.
• Eurofins Scientific: Eurofins is a global testing services group offering bioanalytical, genomics, and immunoassay services across pharma and diagnostics. It is a broad incumbent that competes in biomarker discovery and immune monitoring as part of a wider testing portfolio.
• Labcorp: Labcorp's drug development arm offers central labs, flow cytometry, genomics, and translational biomarker services. It is a broad incumbent overlapping with Talon's clinical trial immune monitoring offering, with significantly greater global reach and pharma MSA coverage.

Emerging players

• Frontage Laboratories: Frontage is a CRO offering bioanalytical, biomarker, and immunoassay services to pharma/biotech. It is an emerging peer in the biomarker CRO space with broader bioanalytical capability than Talon but less depth in single-cell/spatial immune profiling.
• Cytobank (Beckman Coulter Life Sciences): Cytobank provides cloud-based computational analysis for high-dimensional flow and mass cytometry, overlapping with Talon's computational & dynamic analytics layer. It is an enabling/adjacent peer in the immune analytics workflow rather than a full services competitor.
• Bethyl Laboratories: Bethyl provides antibody reagents and custom immunoassay services supporting biomarker discovery research. It overlaps with Talon's biomarker discovery workflow but does not offer integrated multi-omic immune profiling.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/talonbiomarkers

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Talon Biomarkers